3
2

RAPID Reserve Act

7/3/2025, 4:23 AM

Summary of Bill S 2062

The bill "A bill to improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies" was introduced in the 119th Congress on June 12, 2025.

Current Status of Bill S 2062

Bill S 2062 is currently in the status of Bill Introduced since June 12, 2025. Bill S 2062 was introduced during Congress 119 and was introduced to the Senate on June 12, 2025.  Bill S 2062's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of June 12, 2025

Bipartisan Support of Bill S 2062

Total Number of Sponsors
2
Democrat Sponsors
2
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
3
Democrat Cosponsors
1
Republican Cosponsors
2
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 2062

Primary Policy Focus

Alternate Title(s) of Bill S 2062

A bill to improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies.
A bill to improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies.

Comments